#ForResearchOnly - Twitter Hashtag

niks 🍀

@zeyziatira

2 months ago

SINO PO YUNG NAKADARK BLUE?! #forresearchonly

Niiieee💫🧸 @anjrazzzz

2 months ago

Salamat mga Sirssss! 💚 antawaaa ko sa mga nababasa ko, popogi nyo daw po… 😂

4

90

12

2

13K

0

31

3

0

1K

niks 🍀

@zeyziatira

7 months ago

@puddingpodsz #forresearchonly

0

2

0

1K

Vithoba Corleone @DonJuannabe

over 2 years ago

ज्या ज्या नवऱ्यांनी आपापल्या बायकोला तिळगुळ दिले त्यांनी उद्या त्याचा काही फायदा झाला का ह्याची माहिती द्यावी. 🙏🏻🙏🏻 #मकर_संक्रांति #ForResearchOnly

1

2

0

110

👁🙏🏼👁 #SozialeDreigliederung #LovePeaceHarmony @CarolaJojo

over 3 years ago

Vielleicht findet jemand passendere #Adjektive und achtet endlich mal auf die #Verwendung #deutscher #Modalverben in jeder #Denglish #Laborpandemie #Test #Computervirenmodellierung #Asch #Experiment #Milgram #ForResearchOnly🌍🥶❄️💉

Carsten Jahn TEAM HEIMAT ⚫️🔴🟡

@JahnTeam

over 3 years ago

Lustig ist ja die Tatsache, das der T(Fl)op Virologe #Drosten, mit keinem Wort ertwähnt das seine letzten Voraussagen alle falsch waren, das die Impfung mittelschwere und schwere #Nebenwirkungen auslöst und die #Maßnahmen in keinem Verhältnis standen.

5

281

46

0

7K

1

3

0

117

iMDx Inc. @iMDxInc

over 5 years ago

Up to 750,000 patients may be eligible for immunotherapy each year, yet today more than half of patients treated with immunotherapy won't respond. https://t.co/4sEEgSMAvH #forresearchonly #webinar #diagnostics #cancer $OCX

iMDxInc's tweet photo. Up to 750,000 patients may be eligible for immunotherapy each year, yet today more than half of patients treated with immunotherapy won't respond. https://t.co/4sEEgSMAvH #forresearchonly #webinar #diagnostics #cancer $OCX https://t.co/DLCmsfv2KR

0

4

1

0

iMDx Inc. @iMDxInc

over 5 years ago

Data presented in non-small cell lung and triple-negative breast cancer showed that DetermaIO™ showed better predictive ability than PD-L1 https://t.co/4sEEgSuZ77 #forresearchonly #triple-negative #breastcancer #PD-L1 $OCX

iMDxInc's tweet photo. Data presented in non-small cell lung and triple-negative breast cancer showed that DetermaIO™ showed better predictive ability than PD-L1 https://t.co/4sEEgSuZ77 #forresearchonly #triple-negative #breastcancer #PD-L1 $OCX https://t.co/ma6lzCuQKe

0

4

1

0

iMDx Inc. @iMDxInc

over 5 years ago

Data presented in non-small cell lung and triple-negative breast cancer showed that DetermaIO™ showed better predictive ability than PD-L1 https://t.co/4sEEgSuZ77 #forresearchonly #triple-negative #breastcancer #PD-L1 $OCX

0

4

0

iMDx Inc. @iMDxInc

over 5 years ago

Up to 750,000 patients may be eligible for immunotherapy each year, yet today more than half of patients treated with immunotherapy won't respond. https://t.co/4sEEgSMAvH #forresearchonly #webinar #diagnostics #cancer $OCX

0

1

0

iMDx Inc. @iMDxInc

over 5 years ago

Data suggests that DetermaIO™ outperformed PD-L1 in predicting immunotherapy responders as well as non-responders. https://t.co/vrGAT3coJ9 #forresearchonly #Immunotherapy #responders #PD-L1 $OCX

iMDxInc's tweet photo. Data suggests that DetermaIO™ outperformed PD-L1 in predicting immunotherapy responders as well as non-responders. https://t.co/vrGAT3coJ9 #forresearchonly #Immunotherapy #responders #PD-L1 $OCX https://t.co/oa948gmQEa

0

4

0

iMDx Inc. @iMDxInc

over 5 years ago

Data suggests that DetermaIO™ outperformed PD-L1 in predicting immunotherapy responders as well as non-responders. https://t.co/vrGAT3coJ9 #forresearchonly #Immunotherapy #responders #PD-L1 $OCX

0

2

1

0

biboy @princeboobb

almost 7 years ago

People are so unfair ba? They care so much abt how you make them feel pero not at how they make you feel. Interesting 😂🤔 am i like that too? 😮🤔🤔🤔 #forresearchonly

1

14

4

0